| Financial Year |
March 31 2023 |
| Monetary Funds |
5,078,275,916.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
51,174,022.04 |
| Accounts Receivable |
2,652,256,206.35 |
| Advances to Suppliers |
322,777,567.94 |
| Other Receivables |
454,048,242.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
30,652,512.06 |
| Inventories |
49,690,217.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,221,049.25 |
| Total Current Assets |
8,872,102,311.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
159,973,734.69 |
| Investment Properties |
-- |
| Fixed Assetes |
9,731,605,614.46 |
| Under-construction Projects |
170,151,797.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
310,279,266.49 |
| R&D expenses |
7,711,226.39 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
65,890,212.07 |
| Deferred Income Tax Assets |
135,013,825.47 |
| Other Non-Current Assets |
29,665,660.79 |
| Sub-Total of Non-Current Assets |
11,356,790,993.56 |
| Total Assets |
20,228,893,305.33 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
970,422,636.82 |
| Accounts Received In Advance |
301,252.22 |
| Employee Compensation Payable |
88,965,178.83 |
| Taxes Payable |
22,874,513.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
141,218,529.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,614,497.75 |
| Other Current Liabilities |
6,179,371.66 |
| Sub-Total of Current Liabilities |
1,416,966,191.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,424,311.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
95,226,873.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
362,390,329.70 |
| Total Liabilities |
1,779,356,521.24 |
| Paid-In Capital(Or Share Stock) |
4,444,444,444.00 |
| Capital Surplus |
11,709,737,743.13 |
| Surplus Reserve |
164,642,360.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,720,992,121.70 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,449,536,784.09 |
| Owner's Equity（Stockholder's Equity） |
18,449,536,784.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,228,893,305.33 |
